<qa>  What is the primary goal of the study?The primary objectives of the study is to show CD2475101 40mg tablets taken once a day for 16 weeks is superior to the placebo in Change from baseline to Week 16Last Observation Carry Forward, Intent To Treat in inflammatory lesion counts. 